New injection could unclench curved fingers
NCT ID NCT07640425
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called CNT201 for people with Dupuytren's contracture, a condition where fingers bend toward the palm and can't straighten. The drug is injected into the tight cord in the finger to break it down, aiming to restore movement. About 60 adults aged 18 to 75 with at least one affected finger will participate. The main goals are to check safety and see if the finger can straighten within 5 degrees of normal.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUPUYTREN CONTRACTURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A R Houston Medical Pty Ltd.
RECRUITINGKippa-Ring, Queensland, 4021, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping away recurrence: radiation after Dupuytren's treatment put to the test
- Which treatment works best for Dupuytren's? major trial aims to find out
- New surgery technique aims to prevent ugly scars in Dupuytren's patients
- Antioxidant pill may cut opioid use after surgery
- Can radiation after surgery stop Dupuytren's from coming back?
- Study explores how conversations shape patient choices on x-rays and MRIs